Systems biology approaches to the study of cardiovascular drugs

Area of Science:

• Cardiovascular science
• Systems biology
• Pharmacology

Background:

• Atherogenic lipids and chronic inflammation are key drivers of cardiovascular disorders like atherosclerosis.
• The liver plays a crucial role in producing lipid and inflammatory risk factors targeted by cardiovascular drugs.

Purpose of the Study:

• To describe a systems approach for analyzing the effects of a prototype cardiovascular drug.
• To demonstrate how systems biology and bioinformatics can enhance the sensitivity and comprehensiveness of drug effect analysis.

Main Methods:

• Utilizing robust systems biology tools and comprehensive bioinformatics packages.
• Implementing experimental design, tissue collection, and high-quality RNA preparation.
• Performing targeted and untargeted bioinformatical analysis of functional processes and pathways.

Main Results:

• Detection of beneficial and adverse drug effects at the gene and metabolite levels.
• Identification of effects prior to macroscopic manifestation.
• Comprehensive analysis of a prototype cardiovascular drug with known effects.

Conclusions:

• A systems approach, integrating bioinformatics, offers a sensitive method for evaluating cardiovascular drug efficacy and safety.
• This approach allows for early detection of drug-induced changes at molecular levels.
• The described methodology provides a framework for analyzing novel cardiovascular treatment strategies.